ABSTRACT
Background: One factor for the poor health outcomes among adult people with metabolic syndrome (MetS) is poor utilization of disease management resources, which may be attributable to prior experience with pharmacists (PEwP) and perceptions of disease management resource utilization (PMU). Therefore, understanding patients' experience could be critical to improving their perceptions and promoting health outcomes. Objectives: The study explored the influence of PEwP and PMU on the health-related quality of life (HRQoL) of people with MetS. Methods: Data on perceptions of healthcare, medication, and pharmacy services utilization, PEwP, and HRQoL were collected using validated tools via an electronic survey. Chi-square and ordinal regression tests were used to predict the association between PMU, PEwP, and HRQoL. Also, mediation analysis through Haye's model 4 explored the direct and indirect relationship of PMU and PEwP on HRQoL. Results: A total of 706 completed surveys were collected and used for analyses. On average, respondents reported three comorbidities. Of the respondents, 72.0% had good PEwP, while 32.6% had good PMU. Comparatively, 38.4% of those with good PEwP had good PMU, compared to 17.3% of those with poor PEwP. Also, 47.0% of those with good PMU had good HRQoL compared to 35.3% with poor PMU. The odds of having fair or good PMU were nearly triple (OR = 2.97, p < 0.001) among those with good PEwP compared to those with poor PEwP. Also, respondents with good PMU had 58% (OR = 1.58, p = 0.008) higher odds of having fair or good HRQoL. Analysis through bootstrap indicated a significant relationship (BootCI = -0.072, -0.022) between PEwP and HRQoL via respondents' PMU. Conclusions: MetS individuals with good experience and PMU were more likely to have good HRQoL. Prior experience with pharmacists influenced PMU and indirectly impacted HRQoL. Therefore, pharmacists must consider patients' experience and management utilization perceptions to promote health outcome among people with MetS, while implementing interventions.
ABSTRACT
BACKGROUND: This study aimed to investigate the prevalence of arterial hypertension in China. METHODS: The Beijing Eye Study 2006 is a population-based investigation including 3,251 subjects aged 45+ years. Blood pressure measurements were performed for 3,222 (99.1%) subjects. Hypertension was defined as a systolic blood pressure > or =140 mm Hg and/or a diastolic blood pressure > or =90 mm Hg, and/or self-reported current treatment for hypertension. RESULTS: A diastolic blood pressure of >or =90 mm Hg was detected in 106 (3.3%) subjects, and a systolic blood pressure > or =140 mm Hg was measured in 866 (26.9%) subjects. Arterial hypertension was present in 1,500 (46.6%) subjects. Prevalence of arterial hypertension was significantly associated with age (P < 0.001), body mass index (P < 0.001), serum concentration of cholesterol (P = 0.02), diabetes mellitus (P < 0.001; odds ratio: 1.48), family history of hypertension (P < 0.001; odds ratio: 2.96), and rural region (P < 0.001; odds ratio: 2.27). Among the arterial hypertensive subjects, 82.7% were aware of the diagnosis. Awareness of hypertension was significantly associated with urban area, higher age, higher body mass index, and family history of hypertension. Out of the 1,500 hypertensive subjects, 1,106 (73.7%) were treated for arterial hypertension. Out of the treated subjects, 487 (44%) had abnormally high arterial blood pressure measurements. CONCLUSIONS: These survey results underscore the fact that hypertension is highly prevalent, relatively poorly treated, and an escalating health challenge in China. As in other studies, people in metropolitan areas had the highest rates of awareness, treatment, and control. It implies that effective public health measures are needed to enhance the treatment, and control rates in the Chinese population, particularly in the rural regions.
